Biora Therapeutics, Inc.

BIOR

BIORBiora Therapeutics, Inc. US flag

Other OTC

0.22

USD

- -

994,994.00Market Cap

Income Statement (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	128	144	- -	1	- -	- -
+ Sales & Services Revenue	128	144	- -	1	- -	- -
- Cost of Revenue	92	100	- -	- -	- -	- -
+ Cost of Goods & Services	92	100	- -	- -	- -	- -
Gross Profit	36	43	- -	1	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -
- Operating Expenses	150	184	108	119	62	67
+ Selling, General & Admin	101	120	60	73	38	37
+ Research & Development	49	63	48	46	24	30
+ Other Operating Expense	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-114	-140	-108	-118	-62	-67
- Non-Operating (Income) Loss	10	9	35	61	-13	57
+ Interest Expense, Net	7	8	35	13	11	10
+ Interest Expense	9	9	35	13	11	10
- Interest Income	2	1	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	2	1	- -	48	-24	47
Pretax Income	-124	-149	-143	-179	-49	-124
- Income Tax Expense (Benefit)	5	-1	-38	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-129	-148	-105	-179	-49	-124
- Net Extraordinary Losses (Gains)	- -	- -	87	69	-11	- -
+ Discontinued Operations	- -	- -	-87	-69	11	- -
+ Extraord. & Accounting Changes	- -	- -	175	138	-21	- -
Income (Loss) Incl. MI	-129	-148	-193	-247	-38	-124
- Minority Interest	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-129	-148	-193	-247	-38	-124
- Preferred Dividends	- -	81	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-129	-229	-193	-247	-38	-124
EBIT	-114	-140	-108	-118	-62	-67
EBITDA	-108	-135	-106	-116	-61	-67
EBITDA Margin (%)	-84.52	-94.07	-65,543.83	-9,334.4	-19,958.69	-1,664,700
EBITA	-114	-140	-108	-118	-62	-67
Gross Margin (%)	28.05	30.21	100	100	100	100
Operating Margin (%)	-89.27	-97.31	-66,431.48	-9,449.64	-20,256.07	-1,678,575
Profit Margin (%)	-100.88	-102.81	-118,844.44	-19,840.58	-12,510.49	-3,102,875
Sales per Employee	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	32.09	- -	- -	- -	- -
Depreciation Expense	6	5	1	1	1	1
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	2
Basic EPS, GAAP	-1,197.14	-1,631.54	-1,751.88	-643.27	-31,250.61	-78.69
Basic EPS from Cont Ops	-1,197.14	-1,055.51	-954.88	-464.15	-39,991.81	-78.83
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	2
Diluted EPS, GAAP	-1,197.14	-1,631.54	-1,751.88	-643.27	-31,250.61	-78.69
Diluted EPS from Cont Ops	-1,197.14	-1,055.51	-954.88	-464.15	-39,991.81	-78.83

Balance Sheet (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	89	75	126	99	38	19
+ Cash, Cash Equivalents & STI	69	33	92	88	30	15
+ Cash & Cash Equivalents	49	33	92	88	30	15
+ ST Investments	20	- -	- -	- -	- -	- -
+ Accounts & Notes Receiv	8	23	7	1	1	1
+ Accounts Receivable, Net	2	22	7	1	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	6	1	- -	- -	1	1
+ Inventories	8	11	12	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -
+ Other Inventory	8	11	12	- -	- -	- -
+ Other ST Assets	4	8	15	10	7	3
+ Misc ST Assets	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	27	27	28	10	15	12
+ Property, Plant & Equip, Net	15	16	8	4	3	3
+ Property, Plant & Equip	29	33	14	9	7	5
- Accumulated Depreciation	14	17	6	6	4	2
+ LT Investments & Receivables	- -	- -	- -	- -	6	3
+ LT Investments	- -	- -	- -	- -	6	3
+ LT Receivables	- -	- -	- -	- -	- -	- -
+ Other LT Assets	12	11	20	6	6	6
+ Total Intangible Assets	12	11	6	6	6	6
+ Goodwill	6	6	6	6	6	6
+ Other Intangible Assets	6	5	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	14	- -	- -	- -
Total Assets	116	102	154	109	54	31
+ Payables & Accruals	67	88	59	33	15	15
+ Accounts Payable	11	16	17	9	4	3
+ Accrued Taxes	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	56	72	41	24	11	12
+ ST Debt	1	1	- -	- -	1	3
+ ST Borrowings	- -	- -	- -	- -	- -	2
+ ST Finance Leases	1	1	- -	- -	1	1
+ Other ST Liabilities	10	12	14	29	7	45
+ Deferred Revenue	- -	- -	- -	- -	- -	1
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	10	12	13	29	7	44
Total Current Liabilities	78	100	73	62	23	63
+ LT Debt	72	72	160	126	128	45
+ LT Borrowings	71	72	160	126	128	44
+ LT Finance Leases	1	- -	- -	- -	1	1
+ Other LT Liabilities	4	13	29	6	4	25
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	4	13	29	6	4	25
Total Noncurrent Liabilities	75	85	189	132	133	70
Total Liabilities	153	186	261	194	156	133
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	124	283	453	723	744	869
+ Common Stock	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	124	283	453	723	744	869
- Treasury Stock	19	19	19	19	19	19
+ Retained Earnings	-142	-348	-541	-789	-827	-951
+ Other Equity	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-37	-84	-107	-85	-102	-101
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
Total Equity	-37	-84	-107	-85	-102	-101
Total Liabilities & Equity	116	102	154	109	54	31
Shares Outstanding	- -	- -	- -	1	1	3
Number of Employees	- -	- -	- -	- -	- -	- -
Capital Leases - Total	2	1	- -	- -	1	2
Net Debt	22	39	68	38	97	31
Net Debt to Equity	-59.08	-46.79	-63.7	-44.71	-95.15	-30.07
Tangible Common Equity Ratio	-46.81	-104.67	-76.21	-88.6	-228.35	-427.53
Current Ratio	1.14	0.74	1.74	1.6	1.64	0.3
Cash Conversion Cycle	- -	17.2	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	-129	-148	-193	-247	-38	-124
+ Depreciation & Amortization	6	5	1	1	1	1
+ Non-Cash Items	12	44	158	132	-24	66
+ Stock-Based Compensation	2	2	8	12	8	16
+ Deferred Income Taxes	6	- -	- -	- -	- -	- -
+ Asset Impairment Charge	1	1	- -	- -	1	- -
+ Other Non-Cash Adj	2	41	150	120	-33	50
+ Chg in Non-Cash Work Cap	46	-7	-60	-26	-5	9
+ (Inc) Dec in Accts Receiv	- -	9	1	- -	-1	- -
+ (Inc) Dec in Inventories	-3	-4	-1	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-2	-4	-3	1	3	1
+ Inc (Dec) in Accts Payable	48	22	-59	-32	-5	10
+ Inc (Dec) in Other	3	-31	3	4	-2	-2
+ Net Cash From Disc Ops	- -	- -	-73	-27	2	- -
Cash from Operating Activities	-65	-106	-166	-167	-64	-48
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	-5	-4	-4	-1	-1	- -
+ Acq of Fixed Prod Assets	-5	-4	-4	-1	-1	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	-11	1	116	47	9	18
+ Increase in Capital Stock	- -	1	116	47	9	18
+ Decrease in Capital Stock	-11	- -	- -	- -	- -	- -
+ Net Change in LT Investment	61	20	- -	- -	- -	- -
+ Dec in LT Investment	228	31	- -	- -	- -	- -
+ Inc in LT Investment	-167	-11	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	-1	- -	- -	3
+ Net Cash From Disc Ops	- -	- -	-1	- -	- -	3
Cash from Investing Activities	56	17	-5	-1	-1	2
+ Dividends Paid	- -	-4	- -	- -	- -	- -
+ Net Cash From Debt	-2	-1	99	-2	- -	10
+ Cash From Debt	- -	- -	100	- -	- -	10
+ Repayments of Debt	-2	-1	-1	-2	- -	- -
+ Other Financing Activities	- -	79	14	120	-2	3
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	-13	74	230	165	7	31
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -
Net Changes in Cash	-22	-16	59	-4	-58	-15
EBITDA	-108	-135	-106	-116	-61	-67
EBITDA Margin (%)	-84.52	-94.07	-65,543.83	-9,334.4	-19,958.69	-1,664,700
Free Cash Flow	-70	-110	-170	-168	-65	-49
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-192	-71	-170	-65	-39
Free Cash Flow per Basic Share	-648.69	-783.23	-1,541.24	-437.68	-53,406.22	-30.81
Price/Free Cash Flow	- -	- -	-0.9	-1.21	- -	-0.44
Cash Flow to Net Income	0.5	0.72	0.86	0.68	1.69	0.39
Capital Expenditures	-5	-4	-4	-1	-1	- -